home / stock / iccm / iccm news


ICCM News and Press, IceCure Medical Ltd. From 11/08/23

Stock Information

Company Name: IceCure Medical Ltd.
Stock Symbol: ICCM
Market: NASDAQ
Website: icecure-medical.com

Menu

ICCM ICCM Quote ICCM Short ICCM News ICCM Articles ICCM Message Board
Get ICCM Alerts

News, Short Squeeze, Breakout and More Instantly...

ICCM - IceCure Medical to Report Third Quarter 2023 Financial & Operational Results on November 15, 2023

IceCure Medical to Report Third Quarter 2023 Financial & Operational Results on November 15, 2023 IceCure Medical to Report Third Quarter 2023 Financial & Operational Results on November 15, 2023 PR Newswire CAESAREA, Israel , Nov. 8, 2023 /PRNewswire...

ICCM - Substantial Evidence-Based Data Currently Being Generated by 19 Ongoing Studies Using IceCure Medical's ProSense® Cryoablation System

Substantial Evidence-Based Data Currently Being Generated by 19 Ongoing Studies Using IceCure Medical's ProSense® Cryoablation System PR Newswire Independent, non-sponsored studies by doctors using ProSense® to treat cancers of the breast, lung, kidney, and ...

ICCM - IceCure Medical announces receipt of Nasdaq minimum bid price notification

2023-11-03 16:06:13 ET More on IceCure Medical IceCure stock soars 85% in pre-market trading on positive study results IceCure Medical shares plunge 40% on FDA update Seeking Alpha’s Quant Rating on IceCure Medical Historical earnings data for IceCure ...

ICCM - IceCure Medical Announces Receipt of Nasdaq Minimum Bid Price Notification

IceCure Medical Announces Receipt of Nasdaq Minimum Bid Price Notification PR Newswire CAESAREA, Israel , Nov. 3, 2023 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), a developer of the ProSense® System, a minimally-invasive...

ICCM - IceCure's ICE3 Trial Results Demonstrating 96.91% Recurrence Free Rate Featured in a Presentation at BISICON 2023 in India

IceCure's ICE3 Trial Results Demonstrating 96.91% Recurrence Free Rate Featured in a Presentation at BISICON 2023 in India PR Newswire ICE3 trial will be finalized in Q1 2024 IceCure's distributor in India , Novomed, exhibited ProSense® and received a ...

ICCM - Independent Scientific Paper by Doctors Using IceCure's ProSense® Published in Journal of Breast Imaging Presents Advantages of Cryoablation Breast Conserving Over Surgery in Early Breast Cancer Patients

Independent Scientific Paper by Doctors Using IceCure's ProSense® Published in Journal of Breast Imaging Presents Advantages of Cryoablation Breast Conserving Over Surgery in Early Breast Cancer Patients PR Newswire Paper cites IceCure's ICE3 interim clinical study resu...

ICCM - Nano-X, InMode, Teva among notable Israel-based healthcare decliners

2023-10-09 13:00:03 ET More on InMode, Nano-X, etc. Full Of Potential Red Flags: Breaking Down Nano-X Imaging Nano-X Imaging: Cash Burn Makes It A Hold InMode: Bullish Support Failed To Materialize War between Israel and Hamas pushes U.S.-traded Israeli stock...

ICCM - 24/7 Market News Wrap for 6 Oct 2023

2023-10-06 15:43:10 ET DENVER, Colo., Oct 6, 2023 ( www.247marketnews.com )- The following companies were among the listings that we covered this week; IceCure Medical Ltd. (NASDAQ: ICCM), Femasys (NASDAQ: FEMY), SeaStar Medical Holding (NASDAQ: ICU), Siyata Mobile (NASDAQ: SYTA), Vivos...

ICCM - 24/7 Market News Lunch Break 5 Oct 2023

2023-10-05 12:21:19 ET DENVER, Colo., Oct 5, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; IceCure Medical Ltd. (NASDAQ: ICCM), Grom Social Enterprises (NASDAQ: GROM), Euronav (NYSE: EURN), Maiso...

ICCM - 24/7 Market News Snapshot 5 Oct 2023

2023-10-05 10:10:30 ET DENVER, Colo., Oct 5, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; IceCure Medical Ltd. (NASDAQ: ICCM), VS Media Holdings (NASDAQ: VSME), Vivos Therapeutics (NASDAQ: VVOS), Femas...

Previous 10 Next 10